SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering […]
Leadership and Track Record in Scaling Sustainable Fermentation-Based Commercial Products Leads to One of Largest Agreements to Date in Cannabinoid […]
New Candidate Program and Community Forum launched, expanding FactSet’s alternative data ecosystem NORWALK, Conn., Feb. 05, 2019 (GLOBE NEWSWIRE) — […]